ClinicalTrials.govpublic full text
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
parkinson's disease, biib054, alpha-synuclein, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 872633
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.